Triple-negative breast cancer: a review of conventional and advanced therapeutic strategies
Triple-negative breast cancer (TNBC) cells are deficient in estrogen, progesterone and
ERBB2 receptor expression, presenting a particularly challenging therapeutic target due to …
ERBB2 receptor expression, presenting a particularly challenging therapeutic target due to …
Lymph node imaging in patients with primary breast cancer: concurrent diagnostic tools
The detection of lymph node metastasis affects the management of patients with primary
breast cancer significantly in terms of staging, treatment, and prognosis. The main goal for …
breast cancer significantly in terms of staging, treatment, and prognosis. The main goal for …
[HTML][HTML] Histological type and typing of breast carcinomas and the WHO classification changes over time
G Cserni - Pathologica, 2020 - ncbi.nlm.nih.gov
Summary The World Health Organization's new classification of breast tumors has just been
published. This review aims to examine the morphological categorization of breast …
published. This review aims to examine the morphological categorization of breast …
Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer
Breast cancer (BC) is the main cause of cancer-related mortality among women globally.
Despite substantial advances in the identification and management of primary tumors …
Despite substantial advances in the identification and management of primary tumors …
Conformable ultrasound breast patch for deep tissue scanning and imaging
Ultrasound is widely used for tissue imaging such as breast cancer diagnosis; however,
fundamental challenges limit its integration with wearable technologies, namely, imaging …
fundamental challenges limit its integration with wearable technologies, namely, imaging …
Emerging CAR-T cell therapy for the treatment of triple-negative breast cancer
S Dees, R Ganesan, S Singh, IS Grewal - Molecular cancer therapeutics, 2020 - AACR
Triple-negative breast cancer (TNBC), a highly aggressive breast cancer subtype that lacks
estrogen receptor, progesterone receptor, and HER2 expression, does not respond to …
estrogen receptor, progesterone receptor, and HER2 expression, does not respond to …
American joint committee on cancer's staging system for breast cancer: what the radiologist needs to know
S Kalli, A Semine, S Cohen, SP Naber, SS Makim… - Radiographics, 2018 - pubs.rsna.org
The TNM staging system for cancer was developed by Pierre Denoix in France in the 1940s
and 1950s. The North American effort to standardize the TNM system for cancer staging was …
and 1950s. The North American effort to standardize the TNM system for cancer staging was …
Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition …
M Yang, SQ Lin, XY Liu, M Tang, CL Hu… - Frontiers in …, 2023 - frontiersin.org
Background Colorectal cancer (CRC) is among the most common malignant cancers
worldwide, and its development is influenced by inflammation, nutrition, and the immune …
worldwide, and its development is influenced by inflammation, nutrition, and the immune …
The epidemiology of breast cancer
E Arzanova, HN Mayrovitz - Exon Publications, 2022 - exonpublications.com
As of 2020, breast cancer has become the most diagnosed cancer globally, overtaking lung
and prostate cancers. Breast cancer incidence is increasing globally with cases expected to …
and prostate cancers. Breast cancer incidence is increasing globally with cases expected to …
Nanoparticles targeting receptors on breast cancer for efficient delivery of chemotherapeutics
S Jahan, ME Karim, EH Chowdhury - Biomedicines, 2021 - mdpi.com
The journey of chemotherapeutic drugs from the site of administration to the site of action is
confronted by several factors including low bioavailability, uneven distribution in major …
confronted by several factors including low bioavailability, uneven distribution in major …